FiberCel Bone Matrix Recall, Warning Issued After Infection Reports
A FiberCel bone matrix recall follows reports of patients who received the grafts developing post-surgical infections, including tuberculosis.…
«
»
A FiberCel bone matrix recall follows reports of patients who received the grafts developing post-surgical infections, including tuberculosis.…
For years, Medtronic sat on more than 1,000 reports of serious complications linked to its Infuse bone growth products, including life-threatening neck conditions.…
A new report finds that Medtronic or its subsidiaries were responsible for one-fifth of all medical device recalls last year, and raises questions about the company’s commitment to avoid unfair business practices which got it into trouble with the U.S. Justice Department in 2008.…
A $43 million settlement agreement proposes to resolve an investor lawsuit against Medtronic over manipulating studies linked to its Infuse bone growth product.…
A new report indicates that Medtronic waited years to inform the FDA of 1,000 adverse event reports linked to complications with the Medtronic Infuse bone growth products.…
The Supreme Court has been asked to weigh in on whether Medtronic is protected by preemption laws if if illegally promoted the Infuse bone growth system for off-label use.…
The FDA is warning doctors to avoid regular use of bone growth products like Medtronics Infuse on children due to the risk of side effects to their still-growing bones.…
Medtronic saw a major drop in profits, in part because of Infuse settlements…
A $22 million Medtronic Infuse settlement has been reached that resolves 950 claims, but leaves hundreds more unresolved; a number likely to grow as more claims are filed.
…
Medtronic says it faces 1,000 lawsuits over its Infuse bone growth product.…